Lv3
284 积分 2025-12-13 加入
Guselkumab-mediated marked improvement in a case of refractory ulcerative colitis resistant to mirikizumab: evidence for switching between IL-23p19 inhibitors
8天前
已完结
European Crohn’s and Colitis Organisation consensus on dietary management of inflammatory bowel disease
10天前
已关闭
Global consensus statement on the management of pregnancy in inflammatory bowel disease
15天前
已完结
A Systematic Review Assessing Medical Treatment for Rectovaginal and Enterovesical Fistulae in Crohn’s Disease
1个月前
已完结
Outcomes of surgical management of enterovesical fistula in Crohn’s disease: a multi-institutional cohort
1个月前
已完结
Rethinking the dose: A Bayesian meta-analysis of infliximab intensification in acute severe ulcerative colitis
1个月前
已关闭
Fast and Curious: An Algorithmic Approach to Infliximab Dosing in Acute Severe Ulcerative Colitis
1个月前
已完结
Dashboard-Driven Accelerated Infliximab Induction Dosing Increases Infliximab Durability and Reduces Immunogenicity
1个月前
已完结
Intensified versus standard dose infliximab induction therapy for steroid-refractory acute severe ulcerative colitis (PREDICT-UC): an open-label, multicentre, randomised controlled trial
1个月前
已完结
Extraintestinal Manifestations in Inflammatory Bowel Disease: From Pathophysiology to Treatment
1个月前
已完结
皖公网安备34019202002308
